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Summary
Mycobacterium tuberculosis is an intracellular pathogen that is able to avoid destruction by host
immune defenses. Exported proteins of M. tuberculosis, which include proteins localized to the
bacterial surface or secreted into the extracellular environment, are ideally situated to interact with
host factors. As a result, these proteins are attractive candidates for virulence factors, drug targets,
and vaccine components. Here we describe a new β-lactamase reporter system capable of identifying
exported proteins of M. tuberculosis during growth in host cells. Because β-lactams target bacterial
cell wall synthesis, β-lactamases must be exported beyond the cytoplasm to protect against these
drugs. When used in protein fusions, β-lactamase can report on the subcellular location of another
protein as measured by protection from β-lactam antibiotics. Here we demonstrate that a truncated
TEM-1 β-lactamase lacking a signal sequence for export (‘BlaTEM-1) can be used in this manner
directly in a mutant strain of M. tuberculosis lacking the major β-lactamase, BlaC. The ‘BlaTEM-1
reporter conferred β-lactam resistance when fused to both Sec and Tat export signal sequences. We
further demonstrate that β-lactamase fusion proteins report on protein export while M. tuberculosis
is growing in THP-1 macrophage-like cells. This genetic system should facilitate the study of proteins
exclusively exported in the host environment by intracellular M. tuberculosis.
INTRODUCTION
Tuberculosis is responsible for nearly two million deaths each year (World Health
Organization, 2007). Mycobacterium tuberculosis, the causative agent of this disease, is an
intracellular pathogen and the ability of this bacterium to survive and grow in macrophages is
essential to its virulence. Multiple processes are likely employed by M. tuberculosis to avoid
destruction in macrophages. These include residing in a phagosome that fails to mature into
an acidified phagolysosome and resisting reactive radicals (as reviewed in Russell, 2007 and
Zahrt & Deretic, 2002). As in other bacterial pathogens, M. tuberculosis proteins exported
beyond the cytoplasm to the bacterial cell envelope (comprised of the cytoplasmic membrane
and cell wall) or secreted into the environment are ideally positioned to interact with host cell
components and promote survival in macrophages. Consequently, exported and secreted
proteins make good candidates for virulence factors, drug targets for disease intervention, and
vaccine antigens.
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Mycobacteria possess two conserved pathways for exporting proteins: the general secretion
(Sec) pathway and the twin-arginine translocation (Tat) pathway (Braunstein et al., 2001; Kurtz
& Braunstein, 2005; McDonough et al., 2005; Owens et al., 2002; Posey et al., 2006; Saint-
Joanis et al., 2006). These systems recognize precursor proteins synthesized with amino-
terminal signal sequences and transport them across the cytoplasmic membrane (DeLisa et
al., 2003; Mori & Ito, 2001). The proteins exported by these pathways can remain associated
with the cell envelope or be further secreted by the bacterium. The signal sequences of Sec and
Tat substrates share a similar domain structure; however, Tat substrates are distinguished by
the presence of the twin-arginine motif, R-R-x-ϕ-ϕ (ϕ = uncharged residue). The two pathways
also differ in their mode of transport. Sec substrates are translocated across the cytoplasmic
membrane in an unfolded state, whereas Tat substrates are translocated in a folded
conformation. M. tuberculosis also has at least two specialized protein export pathways: the
SecA2-dependent system and the ESX-1 (ESAT-6) system (Braunstein et al., 2003; Guinn et
al., 2004; Hsu et al., 2003; Pym et al., 2003; Stanley et al., 2003). Interestingly, both pathways
appear capable of secreting specific subsets of proteins that lack conventional Sec or Tat signal
sequences.
In M. tuberculosis, proteomic and genetic methods have been used to experimentally identify
proteins exported beyond the cytoplasm (reviewed in Kurtz & Braunstein, 2005). The genetic
methods rely on reporter enzymes that are fused to M. tuberculosis protein sequences and report
on the subcellular location of the fusion proteins (Braunstein et al., 2000; Chubb et al., 1998;
Downing et al., 1999; Lim et al., 1995; Wiker et al., 2000). Surrogate hosts such as non-
pathogenic Mycobacterium smegmatis or Escherichia coli have been used in most of these
studies, often because endogenous enzyme activities in M. tuberculosis precluded their use
directly in the pathogen. The use of surrogate hosts is a problem for identifying proteins that
are only exported by pathogenic M. tuberculosis.
β-lactamase is an export reporter that was not initially employed directly in M. tuberculosis
because of endogenous β-lactam resistance. β-lactamase catalyzes the hydrolysis of β-lactams,
a class of antibiotic that targets cell wall biosynthetic enzymes located outside of the
cytoplasmic membrane. Therefore, β-lactamase must be exported beyond the cytoplasm to
protect the bacterium from the drug. For this reason, when fused to another protein, it can be
used as an export reporter with β-lactam resistance as a powerful indicator of export. We
recently reported that a ΔblaC mutant of M. tuberculosis, lacking the chromosomally encoded
β-lactamase BlaC, is β-lactam sensitive (Flores et al., 2005). Further, we showed that BlaC is
a native Tat substrate and that a truncated ‘BlaC lacking a signal sequence can function as a
reporter of Tat-dependent export directly in a ΔblaC mutant of M. tuberculosis (McDonough
et al., 2005). This was shown by fusing a Tat signal sequence to ‘BlaC and demonstrating that
the resulting hybrid protein confers resistance to the β-lactam antibiotic carbenicillin in the
ΔblaC background. Interestingly, the ‘BlaC reporter works with Tat but not Sec exported
proteins. Here we expanded the β-lactamase tools that can be used directly in M.
tuberculosis by demonstrating that the TEM-1 β-lactamase (BlaTEM-1), originally identified
in a clinical isolate of E. coli (Datta & Kontomichalou, 1965), functions as an export reporter
in the ΔblaC mutant of M. tuberculosis. The ‘BlaTEM-1 reporter has the significant advantage
of being compatible with both Sec and Tat signal sequences.
The proteomic and genetic approaches used in previous work for identifying exported proteins
of M. tuberculosis are limited by their reliance on in vitro grown bacteria. Consequently, a
potentially interesting collection of proteins only exported or secreted while M. tuberculosis
are inside host cells are missed. In this report, we demonstrate that β-lactamase reporters have
the novel capability of identifying M. tuberculosis proteins that are exported during
intracellular growth in β-lactam treated THP-1 macrophage-like cells. The system we describe
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will be of significant value for identifying the most interesting category of exported M.
tuberculosis proteins – those exported during growth in the host environment.
METHODS
Bacterial strains, media and growth conditions
Escherichia coli DH5α was grown in Luria-Bertani medium (Fisher) supplemented with the
following concentrations of antibiotics as required: carbenicillin, 100 µg/ml; kanamycin, 40
µg/ml. M. tuberculosis strains H37Rv (WT), PM638 (ΔblaC, H37Rv) (Flores et al., 2005) and
all derivative strains were cultured in Middlebrook 7H9 medium or on Middlebrook 7H10 agar
medium (Difco; BD Biosciences) supplemented with 10% ADS (0.5% BSA, fraction V
[Roche]; 0.2% dextrose; and 0.85% NaCl), 0.5% glycerol, and 0.05% tween 80 (Fisher).
Antibiotics for mycobacteria were used at the following concentrations: carbenicillin, 50 µg/
ml; kanamycin, 20 µg/ml. 7H10 plates supplemented with carbenicillin lacked tween, as the
combination of tween and carbenicillin appeared detrimental to growth of fusion-expressing
strains.
Construction of ‘blaTEM-1 fusion plasmids
Plasmids used in this study are listed in Table 1. All subcloned PCR products were sequenced
and determined to be error free. Sequence encoding the mature domain (lacking the N-terminal
signal sequence) of E. coli BlaTEM-1 was amplified from pUC19 plasmid DNA (Invitrogen)
using the following primers: TEMbla1 (5’-AGATCTCACCCAGAAACGCTGGTGAAAG)
and TEMbla2 (5’-GTTACCAATGCTTAATCAGTGAGGCACC). The resulting PCR
product was cloned into the pCC1 vector (Epicentre) to generate pJM114. The ‘blaTEM-1
reporter was subcloned as a BglII-BamHI fragment into each of the multi-copy vectors
described below. (i) Δss, ‘blaTEM-1. ‘blaTEM-1 was digested from pJM114, end-filled with
Klenow and cloned into MscI cut pMV261. The resulting plasmid, pJES102, contains the
‘blaTEM-1 reporter without a fused signal sequence cloned downstream of the hsp60 promoter.
(ii) ssplcB-‘blaTEM-1. The ‘blaTEM-1 fragment was subcloned into BamHI cut pMB222. The
resulting plasmid, pJES101, contains an in-frame fusion of DNA encoding the signal sequence
of PlcB/Rv2350c (ssplcB) to ‘blaTEM-1 under the control of the hsp60 promoter. (iii)
ssmpt63-‘blaTEM-1. The ‘blaTEM-1 fragment was subcloned into BamHI cut pMB227. The
resulting plasmid, pJES103, contains an in-frame fusion of ssmpt63 (Rv1926c) to ‘blaTEM-1
under the control of the hsp60 promoter. (iv) ssmpt83-‘blaTEM-1. DNA encoding the signal
sequence and the first 31 amino acids of the mature M. tuberculosis Mpt83 (Rv2873) protein
along with the native mpt83 promoter (Juarez et al., 2001) was amplified from M.
tuberculosis genomic DNA using the following primers: mpt83HindIIIF (5’-
CAAGCTTCGTCGGATCCGTGGTAGGGGATGTC) and mpt83HindIIIR (5’-
CAAGCTTCGGGGTCAGCCATTGCCGCCGTGG) and cloned into the pCR2.1 vector
(Invitrogen) to generate pJES125. A HindIII fragment from pJES125, carrying ssmpt83 and
upstream genomic sequence, was cloned into HindIII cut pJES128 (Table 1). The resulting
plasmid, pJES129, contains an in-frame fusion of ssmpt83 to ‘blaTEM-1 under the control of
the native mpt83 promoter (Pmpt83).
Protein quantification by immunoblot
Whole cell lysates of M. tuberculosis strains were prepared as described previously (Braunstein
et al., 2001) with the following modifications. M. tuberculosis cultures were grown in 5 ml
volumes to mid-exponential phase. The cultures were washed twice and resuspended in PBS
0.02% Tween 80. An equal volume of 10% formalin was added to the washed cultures, which
were then incubated at room temperature for 1 hour with frequent mixing by inversion. The
formalin fixation step was necessary to kill M. tuberculosis before further processing. Bacteria
were then harvested by centrifugation at 3000 RPM, washed once in PBS 0.02% tween to
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remove residual formalin, and bead-beaten lysates were then obtained from each sample.
Protein concentration for each lysate was measured using a bicinchoninic acid protein
quantification kit (Pierce). Lysates were boiled for 10 minutes, subjected to SDS-PAGE and
immunoblots were performed using standard conditions. Primary antibodies specific for
BlaTEM-1 were used at a concentration of 1:5000 (QED Biosciences), and horseradish
peroxidase-conjugated anti- mouse secondary antibodies were used at a concentration of
1:20,000. Bands were visualized using Western Lightning Chemiluminescent Reagent Plus
(PerkinElmer) and quantified using ImageJ Image Processing and Analysis software
(http://rsb.info.nih.gov/ij/). Whole cells lysates with the highest level of expression were
diluted to enable direct comparison of all hybridization signals on a single blot. The
comparative quantification was determined by measuring pixel density of an equal area for
each blotted lysate in duplicate. Signal intensity per µg of whole cell lysate loaded was
determined and is reported as the amount relative to protein detected in the ‘BlaTEM-1
expressing strain.
Macrophage infections
THP-1 cells were maintained in RPMI (Gibco)/10% heat inactivated fetal calf serum (FCS) at
37 °C and 5% CO2. To prepare THP-1 monolayers for infection, cells were spun down at 300
g, washed once in RPMI, then resuspended in RPMI/10% FCS at a concentration of 1 × 106
cells/ml. Cells were seeded into 8-well tissue culture slides at 2 × 105 cells/well and treated
with phorbol myristate acetate (PMA) at a final concentration of 50 ng/ml for 48 hours.
M. tuberculosis was grown to mid-exponential phase OD600 of 0.5–1.0. Immediately prior to
infection, the bacterial culture was pelleted, washed once in PBS containing 0.05% Tween 80
(PBS-Tw), and resuspended in an equal volume of PBS-Tw. The culture was then briefly
sonicated to break up clumps of bacteria, diluted in RPMI/10%FCS medium and added to the
THP-1 monolayer at m.o.i. = 0.1.
THP-1 monolayers were infected with M. tuberculosis strains for 4 hours at 37 °C and 5%
CO2. Overlaying medium was then removed, the monolayers were washed 3 times with RPMI
to remove non-cell associated bacteria, and triplicate wells were lysed and plated to determine
uptake (day 0 time-point). The infected monolayers were then overlaid with RPMI/10% FCS,
or RPMI/10% FCS supplemented with carbenicillin and maintained at 37 °C and 5% CO2. At
3 days post infection, the overlying medium was replenished with RPMI/10% FCS media or
media supplemented with carbenicillin, as appropriate. On days 1, 3 and 5 post-infection,
triplicate wells for each infection were washed to remove antibiotic and lysed with 0.05% SDS.
The resulting lysates were diluted and plated on 7H10 agar to enumerate intracellular bacteria
during the course of infection. On day 0 and day 5 of the infection, cell lysates were also plated
on 7H10 agar supplemented with 50 µg/ml carbenicillin. This demonstrated that selection of
spontaneous β-lactam resistant mutants did not occur during the course of infection. To
determine the appropriate carbenicillin concentration necessary to kill intracellular bacteria,
THP-1 infection experiments were performed with a range of antibiotic concentrations (Fig.
4b). Carbenicillin at 1 mg/ml was determined to be the lowest concentration of antibiotic that
caused optimal killing of sensitive intracellular M. tuberculosis and was used in subsequent
experiments.
RESULTS
'BlaTEM-1 is exported by Sec and Tat signal sequences in M. tuberculosis
β-lactamase is an ideal reporter for protein export because it must be localized beyond the
bacterial cytoplasmic membrane to effectively protect the bacterium from β-lactam antibiotics.
Therefore, it can be used in protein fusions to identify proteins that are extracytoplasmic. An
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attractive feature of a β-lactamase reporter is that a selection for β-lactam resistant colonies
can be performed, as opposed to a more labor-intensive screen. In the past, we showed that the
endogenous β-lactamase of M. tuberculosis BlaC can function as a reporter of export
exclusively by the Tat pathway when expressed in the β-lactam sensitive ΔblaC mutant of M.
tuberculosis or ΔblaS mutant of M. smegmatis (McDonough et al., 2005). Since the Sec
pathway is likely responsible for the majority of protein export in M. tuberculosis, we were
interested in utilizing a β-lactamase reporter that additionally works with Sec exported proteins.
For this reason, we tested the E. coli TEM-1 β-lactamase (BlaTEM-1) which has been used in
other bacteria to report on proteins exported by Sec, Tat, Type II and Type III secretion systems
(Broome-Smith et al., 1990; Charpentier & Oswald, 2004; Sauvonnet & Pugsley, 1996; Stanley
et al., 2002).
A series of multi-copy kanamycin-marked ‘blaTEM-1 plasmids were constructed and
electroporated into the ΔblaC mutant of M. tuberculosis (Fig. 1). The resulting kanamycin
resistant strains were tested for the ability to grow in the presence of 50 µg/ml of the β-lactam
carbenicillin. When the truncated 'blaTEM-1 reporter without a signal sequence was expressed
in the ΔblaC mutant of M. tuberculosis, the strain remained carbenicillin-sensitive. In fact, no
colonies of the strain expressing the truncated ‘BlaTEM-1 grew on agar containing
carbenicillin even after extended incubation (Fig. 1 and Fig 2). However, expression of a hybrid
protein comprised of a Sec signal sequence from Mpt63, a well-established secreted protein
of M. tuberculosis (Horwitz et al., 1995;Manca et al., 1997), fused to 'BlaTEM-1
(ssMpt63-‘BlaTEM-1) protected the ΔblaC mutant from carbenicillin, as was evident by the
ability of this strain to grow on carbenicillin agar plates (Fig. 1 and Fig 2) . We similarly tested
a fusion protein in which the Sec signal sequence of a proven cell wall-associated lipoprotein,
Mpt83 (Hewinson et al., 1996), was fused to ‘BlaTEM-1. This construct also conferred β-
lactam resistance to ΔblaC M. tuberculosis (Fig. 1). Of note, the ssMpt83-‘BlaTEM-1 fusion
protein also included the first 31 amino acids of the mature Mpt83 protein as well as the native
mpt83 promoter which is reported to be active at very low levels in vitro (Hewinson et al.,
1996;Said-Salim et al., 2006).
Finally, we tested the signal sequence of PlcB, a proven cell wall-associated phospholipase C,
for the ability to promote export of enzymatically active ‘BlaTEM-1 (Johansen et al., 1996;
Raynaud et al., 2002). PlcB has a predicted Tat signal sequence, and the ssPlcB-‘BlaTEM-1
fusion also allowed ΔblaC M. tuberculosis to grow in the presence of carbenicillin (Fig. 1).
To determine whether the ssPlcB-'BlaTEM-1 fusion was exported by the Tat pathway, it was
tested in ΔblaS M. smegmatis and in a ΔtatA ΔblaS M. smegmatis double mutant (McDonough
et al., 2005) in two independent experiments. When the ssPlcB-'BlaTEM-1 fusion protein was
expressed in ΔblaS M. smegmatis, 92% of colonies were carbenicillin resistant. However, when
the same construct was expressed in the ΔtatA ΔblaS mutant only an average 7% of colonies
were carbenicillin resistant indicating that the Tat pathway functions in the export of this fusion
protein. To show that a functional Tat pathway was not required for export of the Sec signal
sequence-'BlaTEM-1 fusion, we similarly evaluated export of ssMpt63-'BlaTEM-1. When
expressed in ΔblaS and the ΔtatA ΔblaS mutants, ssMpt63-'BlaTEM-1 conferred carbenicillin
resistance to 90% and 95% of colonies, respectively. This indicated, as expected, no role for
the Tat pathway in exporting a Sec signal sequence-'BlaTEM-1 fusion.
In each example where a M. tuberculosis signal sequence (Sec or Tat) was fused to ‘BlaTEM-1,
ΔblaC M. tuberculosis was protected from β-lactam attack. To demonstrate that the inability
of the ‘BlaTEM-1 reporter lacking a signal sequence to protect against carbenicillin was due
to lack of export, as opposed to lack of expression, whole cell extracts of ‘BlaTEM-1 expression
strains were prepared and assayed for cell-associated β-lactamase. To test for enzyme activity,
we used the chromogenic β-lactam nitrocefin, which turns red following cleavage by β-
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lactamase (O'Callaghan et al., 1972). During a 15 minute incubation the nitrocefin was
hydrolyzed by all strains expressing ‘BlaTEM-1 constructs, while ΔblaC M. tuberculosis
demonstrated no activity, similar to PBS alone (data not shown). Importantly, β-lactamase
activity was detected with the truncated ‘BlaTEM-1 reporter lacking a signal sequence. In fact,
the lysate from the ‘BlaTEM-1 strain converted nitrocefin to the red product almost
instantaneously and faster than any other strain tested. We similarly detected β-lactamase
activity in whole cell lysates of ΔblaC M. tuberculosis expressing the 'BlaC reporter lacking
its native signal sequence.
We also compared the level of each ‘BlaTEM-1 fusion protein present in whole cell lysates
from the respective M. tuberculosis strains by immunoblots with antibodies specific for
BlaTEM-1. This revealed a wide variation in the amount of ‘BlaTEM-1 protein produced by
the different strains (Fig. 3). The non-exported ‘BlaTEM-1 expressed off the hsp60 promoter
(Phsp60) was the most abundant protein detected. Phsp60 is considered a relatively strong
promoter and is, therefore, present on many mycobacterial shuttle vectors (Stover et al., 1991).
In comparison, the Phsp60 driven ssPlcB-‘BlaTEM-1 and ssMpt63-‘BlaTEM-1 were expressed
at lower levels (59% and 0.9% of the level of the non-exported ‘BlaTEM-1 construct,
respectively). Since mpt83 is expressed at relatively low levels in vitro we expected the
ssMpt83-‘BlaTEM-1 fusion to be weakly expressed (Hewinson et al., 1996;Said-Salim et al.,
2006;Schnappinger et al., 2003). In fact, it was nearly undetectable by immunoblot, present at
only 0.4% of the amount of non-exported ‘BlaTEM-1 construct. The bands detected on the
immunoblot are in general agreement with the predicted molecular weight of the expressed
proteins. ‘BlaTEM-1, lacking a signal sequence, has a predicted size of 28 kDa. Since whole
cell lysates were analyzed in these experiments it is possible to see processed protein and/or
uncleaved cytosolic precursor, which may explain the larger sized ssPlcB-‘BlaTEM-1 product.
The signal sequences of PlcB and Mpt63 would add approximately 3 and 4 kDa, while the
Mpt83 signal sequence and fused portion of the mature protein would add approximately 11
kDa, if left intact.
These observations suggested that even though ‘BlaTEM-1 does not promote growth in the
presence of carbenicillin, a significant amount of β-lactamase was produced and accumulated
within the bacterium. Together, our results indicated that in ΔblaC M. tuberculosis 'BlaTEM-1
must be exported to confer protection against β-lactam antibiotics, that β-lactam resistance can
be used to report on export, and that this reporter can be exported by Sec or Tat signal sequences
and is compatible with different levels of expression.
The ΔblaC mutant of M. tuberculosis is sensitive to β-lactams during intracellular growth in
human THP-1 cells
β-lactam antibiotics can be used for clinical treatment of intracellular pathogens such as Listeria
monocytogenes (Safdar & Armstrong, 2003), and have been shown to reduce the population
of phagocytosed Staphylococcus aureus (Barcia-Macay et al., 2006). This indicates that β-
lactams can enter macrophages and inhibit intracellular growth of some bacteria. The ΔblaC
mutant of M. tuberculosis is sensitive to β-lactams in vitro, and we set out to test if this mutation
also makes M. tuberculosis susceptible to β-lactams during growth in host cells.
Intracellular growth of the ΔblaC mutant was not previously evaluated; therefore, we first tested
the ability of this mutant to grow within human monocytic THP-1 cells. THP-1 cells were
infected at a m.o.i. of 0.1 with either the ΔblaC mutant or the virulent parental H37Rv strain.
After a four hour period of infection, the THP-1 monolayer was washed to remove non-cell
associated bacilli and fresh media was added back. Growth over a five day period was assessed
by plating of infected host cell lysates for viable bacilli. The ΔblaC mutant showed no
difference in intracellular growth when compared to H37Rv (Fig. 4a). Of note, we confirmed
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that M. tuberculosis does not grow in the THP-1 culture medium as previously reported (Zhang
et al., 1998).
To determine if the ΔblaC mutant was sensitive to β-lactams during intracellular growth, THP-1
cells were infected with ΔblaC M. tuberculosis and, following the washes to remove
extracellular bacilli, media containing different concentrations of carbenicillin was added to
the infected monolayers. After five days incubation, the infected monolayers were washed to
remove carbenicillin and lysed to plate for viable bacilli. In the absence of carbenicillin, the
ΔblaC mutant grew in THP-1 cells as previously seen. However, as the concentration of
carbenicillin during the intracellular growth period increased, growth of the mutant diminished.
At carbenicillin concentrations of ≥ 0.8 mg/ml substantial killing of the mutant was observed
(Fig. 4b). These results indicated that the ΔblaC mutant is sensitive to β-lactam antibiotics
during intracellular growth, and it suggested that the β-lactamase reporters could be used to
study protein export during intracellular growth. Additional experiments showed that a
concentration of 1 mg/ml carbenicillin was sufficient to achieve significant killing of the
ΔblaC mutant of M. tuberculosis in THP-1 cells, and this concentration was used in all
subsequent experiments.
Export of β-lactamase protects intracellular ΔblaC M. tuberculosis from β-lactam antibiotics
A reporter system that works with intracellularly growing M. tuberculosis would be of great
value for identifying exported proteins that are expressed and exported only during infection.
Having shown that the ΔblaC mutant was sensitive to β-lactams during intracellular growth,
we tested if β-lactamase could be used to report on protein export by M. tuberculosis growing
in host cells. We tested fusion proteins expressing the ‘BlaC and ‘BlaTEM-1 reporters for the
ability to protect the ΔblaC mutant in β-lactam treated THP-1 cells. In each experiment we
compared an exported fusion protein to the truncated reporter alone. To test the ‘BlaC reporter,
which works with Tat exported proteins only, THP-1 cells were infected with the M.
tuberculosis ΔblaC mutant expressing ssPlcB-‘BlaC or ‘BlaC only. Media with or without 1
mg/ml carbenicillin was added and the course of infection was monitored over a five day period.
In the absence of carbenicillin, both strains grew in THP-1 cells during the course of the
experiment. However, in the presence of carbenicillin, the strain expressing the truncated
reporter alone did not grow and was reduced by one log over five days while the strain
expressing the exported ssPlcB-‘BlaC fusion protein was protected from carbenicillin and grew
normally (Fig. 5a).
The ‘BlaTEM-1 fusions were similarly tested. When THP-1 cells were infected with ΔblaC
M. tuberculosis expressing either the exported ssMpt63-‘BlaTEM-1 or the ‘BlaTEM-1 reporter
alone, only the strain expressing ssMpt63-‘BlaTEM-1 fusion grew in THP-1 cells in the
presence of carbenicillin. The non-exported ‘BlaTEM-1 strain was sensitive to the β-lactam
and was reduced in number by one log (Fig. 5b). Similarly, ΔblaC M. tuberculosis exporting
ssMpt83-‘BlaTEM-1 fusion was able to grow in carbenicillin treated THP-1 cells, while the
non-exported ‘BlaTEM-1 construct did not confer resistance to the ΔblaC mutant (Fig. 5c).
These experiments demonstrated that both the Tat specific ‘BlaC reporter and the more
permissive ‘BlaTEM-1 reporter can report on protein export while M. tuberculosis is growing
in β-lactam treated host cells. The use of β-lactamase reporters with intracellular M.
tuberculosis represents a powerful tool for the study and identification of proteins exported
during growth in host cells.
DISCUSSION
The exported proteins of M. tuberculosis have been the subject of research attention for some
time. This stems from the well-established fact that the majority of bacterial virulence factors
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and antigens are proteins exported out of the cytoplasm to the bacterial cell envelope or secreted
out from the bacterium (Finlay & Falkow, 1997). In fact, there is a growing list of M.
tuberculosis exported and secreted proteins shown to contribute to virulence or to development
of a host immune response (Kurtz & Braunstein, 2005). Genetic reporters have proven to be
powerful tools for identifying these extracytoplasmic proteins. The construction of a β-lactam
sensitive ΔblaC mutant of M. tuberculosis opened the door for using β-lactamases as reporters
of protein export directly in M. tuberculosis. The ‘BlaC reporter can be used as a Tat specific
reporter while the ‘BlaTEM-1 reporter, shown here, can work with Sec or Tat signal sequences.
An advantage of β-lactamase reporters is that they can be used to select for exported fusion
proteins, as opposed to more labor intensive screening. In addition, we showed here for the
first time that resistance to β-lactam antibiotics can be used to report on protein export during
intracellular growth of bacteria. Even in more genetically tractable bacterial pathogens, the
identification of proteins exported or secreted from within host cells is a challenge.
Because β-lactams target cell wall modifying enzymes, β-lactamases must be exported in order
to protect against these drugs. This export requirement was previously exploited with fusion
proteins expressed in E. coli and other bacteria grown in vitro (Broome-Smith et al., 1990;
Lee & Hughes, 2006). Here we showed that BlaTEM-1 can also report on protein export
directly in ΔblaC M. tuberculosis. The three M. tuberculosis signal sequences tested in our
study are from well-established secreted or cell- wall associated proteins. Mpt63 (Rv1926c,
16kDa protein) has a predicted Sec signal sequence and is one of the four most abundant M.
tuberculosis proteins secreted into culture media during in vitro growth (Horwitz et al.,
1995). Mpt83 (Rv2873) is a glycosylated lipoprotein (Hewinson et al., 1996; Sutcliffe &
Harrington, 2004) that is exported to the cell wall of M. tuberculosis. Mpt83 has a predicted
Sec signal sequence with a lipoprotein signal peptidase (LspA) cleavage site and the requisite
conserved cysteine for lipid modification. PlcB (Rv2350c, phospholipase C) is a cell wall
associated protein of M. tuberculosis shown to function in virulence (Johansen et al., 1996;
Raynaud et al., 2002). Unlike Mpt63 and Mpt83, PlcB has a predicted Tat signal sequence
including a twin-arginine motif (Dilks et al., 2003). Signal sequences from all three of these
proteins were able to promote export of a fused ‘BlaTEM-1 reporter on the basis of production
of β-lactam resistance. Notably, the ssMpt83-‘BlaTEM- 1 fusion protein was expressed from
the native mpt83 promoter and the fusion protein included the predicted signal sequence plus
31 amino acids of the mature Mpt83 protein. This demonstrated the ability of the reporter to
work with different strength promoters and extended protein sequences. It is important to note
that even though variable levels of fusion protein were detected in M. tuberculosis whole cell
lysates as determined by immunoblot, each exported fusion provided sufficient protection
against 50 µg/ml carbenicillin while the most abundant ‘BlaTEM-1 without an export signal
did not confer β-lactam resistance.
Previously, we showed that the PlcB signal sequence is able to drive export of functional ‘BlaC
in a Tat- and twin RR-dependent manner (McDonough et al., 2005). In E. coli the ‘BlaTEM-1
reporter works with both Sec and Tat signal sequences (Broome-Smith et al., 1990; Stanley
et al., 2002). The Sec and Tat pathways appear essential in M. tuberculosis (Braunstein et al.,
2001; Saint-Joanis et al., 2006; Sassetti et al., 2003). Therefore, to investigate the mode of
export of the ssPlcB-‘BlaTEM-1 fusion protein it was tested in M. smegmatis ΔblaS and in a
M. smegmatis ΔtatA ΔblaS double mutant. A 93% reduction in β-lactam resistant colonies was
observed in the M. smegmatis ΔtatA ΔblaS double mutant. Thus, the Tat pathway is involved
in the export of ssPlcB-‘BlaTEM-1, although other export pathways participate as well. The
signal sequence of PlcB may be promiscuous in targeting the Tat or Sec pathway for export
depending on the folded or unfolded nature of a fused reporter element. Similar results were
recently shown for some predicted Tat signal sequences in E. coli (Tullman-Ercek et al.,
2007).
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In addition to working with the Sec and Tat pathways, the‘BlaTEM-1 reporter has been used
with type II and type III secretion systems of Gram-negative bacteria (Charpentier & Oswald,
2004; Sauvonnet & Pugsley, 1996). Since substrates of the type III secretion system lack
conventional N-terminal signal sequences, it remains possible that the ‘BlaTEM-1 reporter will
also work with non-conventional exported proteins of M. tuberculosis.
An interesting category of exported proteins that has been largely overlooked are those proteins
only expressed and/or exported during the course of infection. We hypothesize that these are
proteins exclusively exported in the host environment including virulence factors and
protective antigens. Further, only a small number of the exported M. tuberculosis proteins
identified in vitro have ever been directly investigated during intracellular growth in host cells
(Kurtz & Braunstein, 2005). For most of these studies, immunomicroscopy was used to localize
the proteins in M. tuberculosis infected macrophages, which required development of suitable
antibodies. We reasoned that if β-lactam antibiotics can reach intracellular ΔblaC M.
tuberculosis, β-lactamase reporters should additionally work during intracellular growth. β-
lactam antibiotics do not normally accumulate in eukaryotic cells; however, antibiotics of this
class freely diffuse in and out of host cells (Tulkens, 1991), and β-lactam antibiotics are used
to treat some intracellular bacterial infections (Safdar & Armstrong, 2003). More specifically,
β-lactams reach intracellular Staphylococcus aureus and Listeria monocytogenes and prevent
growth of these organisms in THP-1 cells (Barcia-Macay et al., 2006; Carryn et al., 2003).
Here we showed that ΔblaC M. tuberculosis in THP-1 cells was also susceptible to
carbenicillin. Thus, BlaC is responsible for M. tuberculosis resistance to β-lactam antibiotics
during intracellular growth, indicating that the chromosomal ΔblaC is a key factor preventing
the use of β-lactams to treat M. tuberculosis infection.
When the set of exported β-lactamase fusion proteins was tested for the ability to protect
ΔblaC M. tuberculosis from β-lactam treatment during intracellular growth, all exported
fusions conferred resistance. In contrast, the truncated non-exported β-lactamase reporters
were not protective. These experiments demonstrated the effectiveness of both ‘BlaC and
‘BlaTEM-1 reporters to identify M. tuberculosis sequences that drive export of each reporter
during growth within host cells. Because the ssMpt83-‘BlaTEM-1 fusion was expressed from
the native promoter, our results indicate that Mpt83, a protein of unknown function, is
expressed and exported during intracellular infection. This result is consistent with the reported
induction of mpt83 in macrophages (Schnappinger et al., 2003).
Several approaches have described proteins exported by M. tuberculosis in vitro, but a different
suite of proteins may be exported during infection of the host. The intracellular β-lactamase
reporter system we describe represents a new genetic tool for studying protein export in M.
tuberculosis. It can be used to directly test the intracellular export of a protein of interest. We
also hope to use it in combination with multiple rounds of infection and selection of β-lactam
resistant clones from a M. tuberculosis fusion library. This should serve to identify the most
interesting category of proteins; namely, those that are exported during intracellular growth
and missed by alternative methods.
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Fig. 1. Schematic representation of signal sequence-‘BlaTEM-1 fusion constructs
Mycobacterial shuttle plasmids were designed to encode fusion proteins of M. tuberculosis
peptide sequence (open boxes) with a truncated ‘BlaTEM-1 protein (gray boxes) lacking its
native signal sequence. The hatched boxes indicate plasmid-derived peptide sequence that is
present as a result of the cloning process. The constructs were driven off the constitutive M.
tuberculosis hsp60 promoter for (a) pJES102/‘blaTEM-1, (b) pJES103/ssmpt63-‘blaTEM-1,
and (d) pJES101/ssplcB-‘blaTEM-1. The native M. tuberculosis promoter located upstream of
the mpt83 operon was used to drive expression of (c) pJES129/ ssmpt83-‘blaTEM-1 (promoters
indicated by arrows). Signal peptidase cleavage sites are indicated by arrowheads and by the
AxA/G recognition motif for PlcB and Mpt63, and the LAGC lipobox recognition motif for
Mpt83. Diagram not to scale; ss, signal sequence.
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Fig. 2. 'BlaTEM-1 does not provide β-lactam-resistance to ΔblaC M. tuberculosis
Plasmids encoding the indicated 'blaTEM-1 fusions were electroporated into M. tuberculosis
ΔblaC. The resulting strains were then plated on 7H10 plates supplemented with either
kanamycin and 0.05% tween or kanamycin and carbenicillin without tween. Plates were
inspected for growth following 21–25 days of incubation. Not shown are colonies expressing
ssMpt83-‘BlaTEM-1 and ssPlcB-‘BlaTEM-1; growth on plates containing carbenicillin for
these strains was similar to that conferred by ssMpt63-‘BlaTEM-1.
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Fig. 3. ‘BlaTEM-1 fusion proteins are detected at different amounts in M. tuberculosis whole cell
lysates
Protein present in whole cell lysates (WCL) from each of the indicated ΔblaC strains were
separated by SDS-PAGE and immunoblotted using primary antibody specific for BlaTEM-1.
Comparative signal was quantified by measuring pixel density of an equal area for each blotted
lysate in duplicate. Average signal intensity per µg of WCL is reported as the amount relative
to protein detected in the ‘BlaTEM-1 expressing strain. Due to the different amounts of protein
in each strain, it was necessary to load dilutions of the ‘BlaTEM-1 and ssPlcB-‘BlaTEM-1
expressing lysates so that signal from less abundant protein fusions could be simultaneously
detected. There was no detectable signal with the WCL from the ΔblaC mutant carrying empty
pMV261 plasmid.
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Fig. 4. The ΔblaC mutant of M. tuberculosis does not have a growth defect and is sensitive to β-
lactam antibiotic in human THP-1 macrophage-like cells
(a) THP-1 cells were seeded into 8 well chamber slides, and triplicate wells were infected with
either WT H37Rv or ΔblaC M. tuberculosis at a m.o.i. of 0.1 bacilli per macrophage. At 4
hours (Day 0), 1, 3 and 5 days post infection, infected wells were washed, lysed, and plated
for intracellular bacteria. Error bars represent standard error of the mean of c.f.u. in triplicate
wells. (b) THP-1 cells were infected with ΔblaC M. tuberculosis as in (a). Following a 4-hour
uptake period, wells were washed and indicated concentrations of carbenicillin were added to
infected wells. Infected cells were lysed and plated at 4 hours (Day 0) and 5 days post infection
to enumerate intracellular bacteria. Dashed line represents average intracellular CFU at 4 hours
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post infection. Error bars represent standard error of the mean of quadruplicate wells combined
from two replicates.
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Fig. 5. M. tuberculosis signal sequences fused to ‘BlaC and ‘BlaTEM-1 protect intracellular bacilli
from β-lactam antibiotics
THP-1 macrophage like cells were infected in triplicate wells with (a) M. tuberculosis
ΔblaC expressing either ssPlcB-‘BlaC or ‘BlaC, (b) M. tuberculosis ΔblaC expressing either
‘BlaTEM-1 or ssMpt63‘BlaTEM-1 or (c) M. tuberculosis blaC expressing ‘BlaTEM-1or
ssMpt83-‘BlaTEM-1. Infected cells were then left untreated or treated with 1 mg/ml
carbenicillin (carb). Wells were washed, lysed and plated 4 hours (d 0), 1, 3 and 5 days post
infection. Each experiment was replicated 3 times in the case of (a) and (b), and 4 times in (c),
with similar results.
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Table 1
Plasmids used in this study
Plasmid Genotype Description Source
pCC1 cat oriV ori2 CopyControl (single copy) blunt cloning
vector
Epicentre
pCR2.1 bla aph ColE1 TA cloning vector Invitrogen
pMV261.kan aph Phsp60 oriM ColE1 Multicopy mycobacterial shuttle plasmid (Stover et al., 1991a)
pMB219 aph oriM ColE1 Multicopy mycobacterial shuttle plasmid This work
pMB222 aph Phsp60-ssplcB (M.
tuberculosis) oriM ColE1
M. tuberculosis plcB signal sequence in
pMV261 under control of hsp60 promoter
(McDonough et al.,
2005)
pMB227 aph Phsp60-ssmpt63 (M.
tuberculosis) oriM ColE1
M. tuberculosis mpt63 signal sequence in
pMV261 under control of hsp60 promoter
(McDonough et al.,
2005)
pMB228 aph Phsp60-ssmpt63-‘blaC (M.
tuberculosis) oriM ColE1
M. tuberculosis ssmpt63-‘blaC in pMV261
under control of hsp60 promoter
(McDonough et al.,
2005)
pJM109 aph Phsp60-ssfbpB-‘blaC (M.
tuberculosis) oriM ColE1
M. tuberculosis ssfbpB-‘blaC in pMV261
under control of hsp60 promoter
(McDonough et al.,
2005)
pJM111 aph Phsp60-ssplcB-‘blaC (M.
tuberculosis) oriM ColE1
M. tuberculosis ssplcB-‘blaC in pMV261
under control of hsp60 promoter
(McDonough et al.,
2005)
pJM113 aph Phsp60-‘blaC (M. tuberculosis)
oriM ColE1
M. tuberculosis ‘blaC (no signal sequence)
in pMV261 under control of hsp60 promoter
(McDonough et al.,
2005)
pJM114 cat oriV ori2 E. coli ‘blaTEM-1 cloned into pCC1 This work
pJES101 aph Phsp60-ssplcB-‘blaTEM-1 (E.
coli) oriM ColE1
’blaTEM-1 from pJM114 cloned into
pMB222
This work
pJES102 aph Phsp60-‘blaTEM-1 (E. coli)
oriM ColE1
blaTEM-1 from pJM114 cloned into
pMV261
This work
pJES103 aph Phsp60-ssmpt63-‘blaTEM- 1
(E. coli) oriM ColE1
’blaTEM-1 from pJM114 cloned into
pMB227
This work
pJES125 bla aph ColE1 M. tuberculosis mpt83 signal sequence and
upstream sequence cloned into pCR2.1
This work
pJES128 aph oriM ColE1 blaTEM-1 from pJM114 cloned into BamHI-
linearized pMB219
This work
pJES129 aph Pmpt83-ssmpt83-‘blaTEM- 1
(E. coli) oriM ColE1
M. tuberculosis mpt83 signal sequence and
upstream sequence from pJES125 cloned
into pJES128
This work
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